The Inflation Reduction Act of 2022 (IRA), signed into law last August, seeks to overhaul the way Medicare buys and pays for prescription drugs. A regulatory undertaking of this scope is certain to generate.
Centers for Medicare & Medicaid Services CMS issued fact sheet, initial guidance documents on Medicare Prescription Drug Inflation Rebate Program for Medicare Parts B and D, critical component of sweeping prescription drug pricing changes from Inflation Reduction Act of 2022
On February 9, 2023, the Centers for Medicare & Medicaid Services (“CMS”) issued a fact sheet and its initial guidance documents addressing the Medicare Prescription Drug Inflation.
The Inflation Reduction Act of 2022 (IRA), signed into law last August, seeks to overhaul the way Medicare buys and pays for prescription drugs. A regulatory undertaking of this scope.